Date of event
Thursday, October 22, 2020 - 5:00 pm -
Thursday, October 22, 2020 - 6:00 pm
Continuing Education Credits

Content Contributors

American Association for the Study of Liver Diseases

AASLD COVID-19 Clinical Oversight Subcommittee


  • Natasha Martin, PhD
    University of California, San Diego
  • Don C Des Jarlais, PhD
    New York University
  • David L. Thomas, MD
    Johns Hopkins University School of Medicine


  • John W. Ward, MD
    Coalition for Global Hepatitis Elimination


  • Nancy Reau, MD, FAASLD
    Rush University Medical Center
  • Andrew Reynolds
    San Francisco AIDS Foundation


As COVID-19 has had a profound impact on the entire health care system, COVID-19 has also had a major impact on goal of global elimination of viral hepatitis.

This webinar will:

  • Discuss the impact of SARs-CoV-2 on the viral care cascade
  • Identify services disrupted by COVID19 that will impact the future of HCV elimination in the US
  • Outline innovative alternatives to minimize the influence of COVID19 on viral hepatitis elimination

Presenter Bio

Dr. Don Des Jarlais is a leader in the fields of AIDS and injecting drug use, and has published extensively on these topics including articles in The New England Journal of Medicine, JAMA, Science, and Nature.

He is active in international research, having collaborated on studies in many different countries. He serves as a consultant to various institutions, including the US Centers for Disease Control and Prevention, the National Institute of Drug Abuse, the National Academy of Sciences, and the World Health Organization.

Dr. Des Jarlais’ research has received numerous awards, including a New York State Department of Health Commissioner’s award for promoting the health of persons who use drugs. He formerly served as a commissioner for the National Commission on AIDS; as a core group member of the UNAIDS Reference Group on HIV and Injecting Drug Use; and as a member of the President’s Emergency Plan for AIDS Relief (PEPFAR) Scientific Advisory Board.

Dr. Des Jarlais is also an adjunct faculty of psychiatry and preventive medicine at Icahn School of Medicine at Mount Sinai, and guest investigator at Rockefeller University in New York.

Photo of Don C. Des Jarlais, PhD